These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1533022)

  • 1. Nafarelin versus leuprolide in ovulation induction for in vitro fertilization: a randomized clinical trial.
    Penzias AS; Shamma FN; Gutmann JN; Jones EE; DeCherney AH; Lavy G
    Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):739-42. PubMed ID: 1533022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nafarelin acetate for pituitary down-regulation in in vitro fertilization. Comparison of two dosages.
    Yuzpe AA; Nisker JA; Kaplan BR; Tummon IS; Auckland J
    J Reprod Med; 1995 Feb; 40(2):83-8. PubMed ID: 7738933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between nafarelin and leuprolide acetate for in vitro fertilization: preliminary clinical study.
    Dantas ZN; Vicino M; Balmaceda JP; Asch RH; Stone SC
    Fertil Steril; 1994 Apr; 61(4):705-8. PubMed ID: 8150114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovulation induction with GnRH agonist and human menopausal gonadotropins: response in patients with one versus two ovaries.
    Penzias AS; Gutmann JN; Shamma FN; LaMorte AI; DeCherney AH
    Int J Fertil Menopausal Stud; 1993; 38(5):270-3. PubMed ID: 8298665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination.
    Duffy DA; Manzi D; Benadiva C; Maier D; Saunders M; Nulsen J
    Fertil Steril; 2006 Feb; 85(2):407-11. PubMed ID: 16595219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
    Garcia JE; Padilla SL; Bayati J; Baramki TA
    Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nafarelin acetate for pituitary suppressions in in-vitro fertilisation cycles--a Singaporean experience.
    Loh SK; Leong NK
    Singapore Med J; 1999 Dec; 40(12):752-5. PubMed ID: 10709427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of nafarelin acetate versus leuprolide acetate in conjunction with human menopausal gonadotropins for superovulation/intrauterine insemination.
    Schmidt-Sarosi CL; Yerovi LA
    Int J Fertil Menopausal Stud; 1994; 39(1):20-5. PubMed ID: 8167676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders.
    DiLuigi AJ; Engmann L; Schmidt DW; Benadiva CA; Nulsen JC
    Fertil Steril; 2011 Jun; 95(8):2531-3. PubMed ID: 21324455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite responses to the addition of leuprolide acetate to human menopausal gonadotropin therapy in two perimenopausal women.
    Check JH; Adelson HG
    Int J Fertil; 1990; 35(6):343-6. PubMed ID: 1981209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leuprolide acetate for inducing ovulation in women undergoing ovarian stimulation.
    diDonato P; Nola VF; Pittman TV; Marr V; Stubbs C; Meldrum DR
    J Reprod Med; 1995 Oct; 40(10):715-6. PubMed ID: 8551474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of a GnRH agonist, leuprolide acetate, into regimens with exogenous gonadotropins to produce ovarian stimulation and ovulation in the nonpregnant squirrel monkey.
    Kuehl TJ; Davis TW; Young C; Nunez P; Robinson MR; Huddleston KP; Wincek TJ; Pliego JF; Dukelow WR
    Am J Primatol; 1999 Oct; 49(2):153-64. PubMed ID: 10466574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A randomized, controlled trial comparing follicle stimulating hormone (FSH) to human menopausal gonadotropin (hMG) in fertilization in vitro].
    Daya S; Gumby J; Hughes EG; Collins JA; Sagle MA
    Contracept Fertil Sex; 1995 Dec; 23(12):766-71. PubMed ID: 8556078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of using ganirelix acetate versus a 4-day follicular phase leuprolide acetate protocol in unselected women undergoing in vitro fertilization.
    Posada MN; Vlahos NP; Jurema MW; Bracero NJ; Wallach EE; Garcia JE
    Fertil Steril; 2003 Jul; 80(1):103-10. PubMed ID: 12849810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nafarelin versus leuprolide in ovulation induction for in vitro fertilization: a randomized clinical trial.
    Lydic ML; Jacobs SL
    Obstet Gynecol; 1992 Oct; 80(4):727-9. PubMed ID: 1407904
    [No Abstract]   [Full Text] [Related]  

  • 19. Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization.
    Tsai HD; Chen CM; Lo HY; Chang CC
    Hum Reprod; 1995 Nov; 10(11):2909-12. PubMed ID: 8747042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomized comparison of two gonadotrophin-releasing hormone agonists, nafarelin acetate and buserelin acetate, in in-vitro fertilization-embryo transfer.
    Goldman JA; Dicker D; Feldberg D; Ashkenazi J; Voliowich I
    Hum Reprod; 1994 Feb; 9(2):226-8. PubMed ID: 8027276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.